abm offers a broad collection of human, mouse, canine, and other mammalian tumor cell lines, including specialized models not found in standard repositories. Use this page to understand where tumor cell lines fit, choose a model for your study, and browse the collection.
A tumor cell line is a cancer cell population derived from a malignant tumor and adapted for continuous growth in culture. These cells carry the changes needed for unlimited proliferation — loss of contact inhibition and dysregulated oncogenes or tumor suppressors such as MYC, RAS, and TP53.
This sets them apart from primary cells, which retain native physiology but have a finite lifespan, and normal immortalized lines, which grow indefinitely but are non-tumorigenic. Depending on tumor type, they can grow as adherent monolayers or in suspension, while their stable genetic background supports reproducible long-term studies.
Tumor cell lines sit at the center of many stages of oncology research, from early target discovery through preclinical drug development.
Selecting a tumor cell line is as much about matching biology to your research question as it is about availability. Consider species and tissue of origin, mutation status, growth format, doubling time and morphology, and passage history or authentication status.
Once you've identified the tumor background that fits your study, you can either add a defined genetic change or move into a more specialized disease- or species-focused model.
abm's 1,000+ stable cell line portfolio includes ready-to-use knockout, overexpression, and reporter models in common tumor backgrounds such as HeLa, MCF-7, A549, and HCT116. Custom generation is also available when the target or background you need is not already in the catalog.
Need a CRISPR knockout? Explore the CRISPR Stable Knockout Service →For studies beyond standard human tumor panels, abm's Special Cell Line Collections bring unique resources together in one place.
Cell line misidentification and contamination are well-documented risks in cancer research. abm supports cell line quality with STR-based identity verification, mycoplasma testing, and Certificates of Analysis.
Already have a line in your freezer? Standalone authentication and mycoplasma detection or decontamination services are available for requalification.
Browse the collection by species, bio system, or cell type to narrow the results to models relevant to your study.
Explore adjacent collections and services that can support engineered models, alternative cell backgrounds, 3D systems, and long-term cell line protection.
1,000+ ready-to-use gene knockout, overexpression, and reporter lines.
Explore Stable Cell Lines →Pre-validated knockout lines across a range of backgrounds.
Browse CRISPR KO Lines →The broader collection of non-tumor and tumor-derived immortalized cells.
Explore Immortalized Cells →Spheroid and organoid platforms for physiologically relevant tumor modelling.
Explore 3D & Organoid →Curated, disease- and species-focused panels including Sloan Kettering, breast, colon, and oral cancer collections.
Explore Collections →Backup cryopreservation to protect valuable or hard-to-replace lines.
Learn About Coverage →A tumor cell line is a population of cancer cells derived from a malignant tumor that proliferates indefinitely in culture. This immortalization lets researchers expand, freeze, and reuse the same genetically stable population across many experiments.
Primary cells are isolated from tissue and have a finite lifespan before senescence. Tumor cell lines are already transformed and divide continuously, making them better suited to long-term or high-throughput studies.
abm's collection spans human, mouse, canine, and other mammalian species, including lines not available through standard repositories such as ATCC. This supports comparative oncology and cross-species target validation.
Yes — abm's cell lines are quality-controlled for identity and contamination, with Certificates of Analysis available through the CoA Library. abm also offers standalone Cell Line Authentication and Mycoplasma Detection & Decontamination services.
Yes. abm's Stable Cell Line portfolio includes 1,000+ ready-to-use lines with knockouts, overexpression constructs, and reporters in common tumor backgrounds. For targets not yet available off the shelf, abm's Stable Cell Line Generation and CRISPR Stable Knockout services can build a custom line.
Comparative oncology studies naturally occurring cancers in animals, most often dogs, to better understand tumor biology and drug response in humans. Canine tumors often share genetic and clinical features with human cancers, making them a valuable translational research resource.
They're used for cytotoxicity screening, mechanism-of-action studies, biomarker validation, and as a source population for xenograft or 3D spheroid models. Their consistent genetic background keeps results comparable across screens and labs.
Yes — abm maintains curated collections including the Sloan Kettering Tumor Cell Line Collection and dedicated breast, colon, and oral cancer cell line collections for cancer-type-specific studies.
abm scientific support can help with tumor type, species, culture requirements, and engineered cell line options for your study.
